Melatonin’s Heart Protective Effects Not Related to Its Antioxidant Properties
Antiarrhythmic benefit from melatonin is distinct from its antioxidant effect
Orlando, Fla. (April 9, 2019)—Although melatonin does improve the outcomes of induced heart attacks in rats, those improvements are not the result of its antioxidant effect, new research finds. The study comparing antioxidant activity and heart protection will be presented today at the American Physiological Society (APS) annual meeting at Experimental Biology 2019 in Orlando, Fla.
Antiarrhythmic agents are substances that treat irregular electrical activity in the heart. Melatonin has previously been shown to have antiarrhythmic effects, with the assumption that this was due to its known antioxidant properties. In this current study, an international team of researchers examined precisely how melatonin affected the heart in a rat model of heart attacks.
One group of rats was given 10 mg of melatonin daily for seven days, while another received a placebo. Researchers then measured the electrical activity in the rats’ hearts before, during and after a cardiac event. They later examined the hearts for measures of oxidative stress and antioxidant activity.
Ventricular tachycardia (VT) and ventricular fibrillation (VF) are two kinds of dangerous irregular electrical activity in the heart that can result from a heart attack. Incidence of both VT and VF was reduced in melatonin-treated rats. A marker of antioxidant activity was also higher in the treated rats. However, there was no association between the presence of oxidative stress and incidence of irregular electrical activity.
In previous work, the research team observed that blocking melatonin-specific receptors removed the antiarrhythmic benefit of melatonin. When taken together with this current study, these results suggest that melatonin’s protective effects for the heart “are related to its antiarrhythmic action, and this effect is related not to antioxidative properties but to melatonin receptor stimulation,” said lead author Jan Azarov, PhD, of the Komi Science Center, Komi Republic, Russian Federation.
Jan Azarov, PhD, of the Institute of Physiology of the Komi Science Center, Syktyvkar, Komi Republic, Russian Federation, will present the poster “Antiarrhythmic effects of chronic melatonin treatment are not associated with its antioxidative action in rat myocardial ischemia/reperfusion model” on Tuesday, April 9, in West Hall B of the exhibit hall of the Orange County Convention Center.
NOTE TO JOURNALISTS: To schedule an interview with a member of the research team, please contact the APS Communications Office or 301-634-7209. Find more research highlights in the APS Press Room.
About Experimental Biology 2019
Experimental Biology is an annual meeting comprised of more than 14,000 scientists and exhibitors from five sponsoring societies and multiple guest societies. With a mission to share the newest scientific concepts and research findings shaping clinical advances, the meeting offers an unparalleled opportunity for exchange among scientists from across the United States and the world who represent dozens of scientific areas, from laboratory to translational to clinical research.
Physiology is the study of how molecules, cells, tissues and organs function in health and disease. Established in 1887, the American Physiological Society (APS) was the first U.S. society in the biomedical sciences field. The Society represents more than 10,500 members and publishes 15 peer-reviewed journals with a worldwide readership.